Companies Cryptocurrencies
PDS Biotechnology Corp
PDS Biotechnology Corp
Exchange: NasdaqGS
IPO Date: 01/10/2015
CEO: Dr. Frank Bedu-Addo
Biotechnology Healthcare 🔗
  • PDSB
    symbol
  • 16.38
    price
  • 465581824
    market cap
  • -0.1800003
    changes
If you bought

shares of PDS Biotechnology Corp (PDSB) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. The company is headquartered in Princeton, New Jersey and currently employs 14 full-time employees. Its therapies are developed for the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Versamune is its synthetic lipid-based immunotherapy platform. Its lead product candidate, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. Its pipeline also includes PDS0102, PDS0103 and PDS0104. Its pipeline of Versamune-based products are all administered by subcutaneous injection .DS0102 is being developed for the treatment of prostate and breast cancers. PDS0103 is based on novel agonist antigens of the mucin-1 (MUC-1) oncogenic C-terminal region. PDS0104 is being developed for the treatment of melanoma.

Address: 25B VREELAND ROAD Florham Park NEW JERSEY 08540

Stay updated.